PAZEO

This brand name is authorized in Canada, Ecuador, Singapore, United States

Active ingredients

The drug PAZEO contains one active pharmaceutical ingredient (API):

1 Olopatadine
UNII 2XG66W44KF - OLOPATADINE HYDROCHLORIDE

Olopatadine is a potent selective antiallergic/antihistaminic agent that exerts its effects through multiple distinct mechanisms of action.

Read about Olopatadine

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
PAZEO Ophthalmic solution FDA, National Drug Code (US) MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
S01GX09 Olopatadine S Sensory organs → S01 Ophthalmologicals → S01G Decongestants and antiallergics → S01GX Other antiallergics
Discover more medicines within S01GX09

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: CA Health Products and Food Branch Identifier(s): 02458551
Country: EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria Identifier(s): 1883-MEE-0316
Country: SG Health Sciences Authority Identifier(s): 15242P
Country: US FDA, National Drug Code Identifier(s): 0065-4273

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.